LM
Director, Regulatory & Scientific Affairs
Get the full picture
Sign in to uncover key details.
Diagnostics for the Real World
Manufacturing · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Science Village, Saffron Walden, Essex, ...Phone Number
(408) 773-1511Website
www.drw-ltd.comRevenue
<$5 MillionIndustry
About Diagnostics for the Real World
DRW specializes in innovative point of care (POC) diagnostics aimed at addressing serious infectious diseases. Their flagship product, the SAMBA Platform, offers decentralized molecular testing that enables prompt clinical intervention at the point of care. The company serves healthcare providers, particularly NHS hospitals, by enhancing patient care through rapid molecular diagnostics. With a commitment to high performance and user-friendly solutions, DRW continues to lead advancements in the diagnostics field.Explore more
Diagnostics for the Real World Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Diagnostics for the Real World
Compare insights from companies similar to Diagnostics for the Real World, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Diagnostics for the Real ...
<$5M
51-200
Private
-
2002
KT
Katrina TranRegulatory Affairs Director, Quality Assurance
Diagnostics for the Real World Tech Stack
A closer look at the technologies used by Diagnostics for the Real World
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Diagnostics for the Real World
Sign Up For FreeTo access detailed company insights
DRW specializes in innovative point of care (POC) diagnostics aimed at addressing serious infectious diseases. Their flagship product, the SAMBA Platform, offers decentralized molecular testing that enables prompt clinical intervention at the point of care. The company serves healthcare providers, particularly NHS hospitals, by enhancing patient ca... Read More
